Research graph
References from Metabolic Reprogramming After Left Ventricular Assist Device. Local targets link to admitted publications; unresolved targets remain external evidence.
Left ventricular assist device and drug therapy for the reversal of heart failure
10.1056/nejmoa053063 · 2006 · External reference
Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure
10.1161/01.cir.97.23.2316 · 1998 · External reference
Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery
10.1016/j.jacc.2013.01.072 · 2013 · External reference
Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties
10.1016/j.jacc.2004.11.042 · 2005 · External reference
Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness
10.1161/circulationaha.104.515106 · 2005 · External reference
Unresolved reference
External reference
The failing heart relies on ketone bodies as a fuel
10.1161/circulationaha.115.017355 · 2016 · External reference
Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure
10.1161/circulationaha.115.017545 · 2016 · External reference
Ketones step to the plate: a game changer for metabolic remodeling in heart failure?
10.1161/circulationaha.116.021230 · 2016 · External reference
Failing heart and starving brain: ketone bodies to the rescue
10.1161/circulationaha.116.022141 · 2016 · External reference
Evidence of glycolysis up-regulation and pyruvate mitochondrial oxidation mismatch during mechanical unloading of the failing human heart: implications for cardiac reloading and conditioning
2016 · External reference
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
10.1016/s0735-1097(02)01967-8 · 2002 · External reference
An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in patients with congestive heart failure
2001 · External reference
Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategies
10.2165/00129784-200404050-00001 · 2004 · External reference
Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure
10.1161/01.cir.103.20.2441 · 2001 · External reference
Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure
10.1161/circulationaha.111.060889 · 2012 · External reference
Chronic heart failure: a reversible metabolic syndrome?
10.1161/circulationaha.112.108316 · 2012 · External reference
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
10.1016/s0140-6736(63)91500-9 · 1963 · External reference
